Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2000
06/15/2000WO2000033864A1 Remedies for tactile failures
06/15/2000WO2000033862A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000WO2000033858A1 Cancer treatment composition and method using natural plant essential oils with signal transduction modulators
06/15/2000WO2000033857A1 Cancer treatment composition and method using natural plant essential oils
06/15/2000WO2000033856A1 Cancer treatment composition and method using signal transduction modulators and natural plant essential oils
06/15/2000WO2000033854A1 Preparation that contains oligosaccharides and probiotics
06/15/2000WO2000033851A1 Peritoneal dialysis solution containing modified icodextrins
06/15/2000WO2000033850A1 Remedies for hyperammonemia
06/15/2000WO2000033849A1 Use of ibandronate for promoting osseointegration of endoprostheses
06/15/2000WO2000033848A1 Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
06/15/2000WO2000033847A1 Micronized eplerenone compositions
06/15/2000WO2000033845A1 Remedial agent for erectile dysfunction
06/15/2000WO2000033844A1 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
06/15/2000WO2000033843A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
06/15/2000WO2000033842A1 Myt1 kinase inhibitors
06/15/2000WO2000033841A1 Myt1 kinase inhibitors
06/15/2000WO2000033840A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis
06/15/2000WO2000033839A1 Non-peptide antagonists of glp-1 receptor and methods of use
06/15/2000WO2000033838A1 Vitronectin receptor antagonist
06/15/2000WO2000033837A2 Myt1 kinase inhibitors
06/15/2000WO2000033835A1 Controlled-release dosage forms comprising zolpidem or a salt thereof
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033833A1 Palladium-substituted bacteriochlorophyll derivatives and use thereof
06/15/2000WO2000033832A1 Chemical composition for treating cervical intraepithelial neoplasia i, ii, iii, iv and cervicitis
06/15/2000WO2000033831A1 Combinations of st. john's wort and fatty acids
06/15/2000WO2000033830A1 An animal model and compounds identified via this model for treatment of chronic pain
06/15/2000WO2000033829A1 Use of poly (hexamethylene) biguanide for producing an agent for promoting the healing of uninfected wounds
06/15/2000WO2000033828A1 Agent for lowering endothelin levels
06/15/2000WO2000033827A1 Bupropion to treat viral diseases
06/15/2000WO2000033826A1 Anticancer agents based on prevention of protein prenylation
06/15/2000WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction
06/15/2000WO2000033824A2 Bioflavonoids, anthocyanins and phenolic compounds from cherries for inhibiting inflammation
06/15/2000WO2000033823A2 Methods of using temozolomide in the treatment of cancers
06/15/2000WO2000033822A1 Active ingredient matrix in the form of a biologically resorbable porous non-woven made of collagen fibrils, method for the production and use thereof
06/15/2000WO2000033820A2 Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations
06/15/2000WO2000033817A1 Phospholipid compositions
06/15/2000WO2000033815A1 Fungicide-containing powdery aerosol preparations
06/15/2000WO2000033812A2 Transdermal patch for delivering volatile liquid drugs
06/15/2000WO2000033811A2 Improvements in or relating to powders
06/15/2000WO2000033796A1 Device, method, and composition for skin cleansing
06/15/2000WO2000033790A2 Methods and compositions for prevention and treatment of arterial lesions with non-steroidal anti-inflammatory drugs
06/15/2000WO2000033787A2 Deodorant cosmetic composition
06/15/2000WO2000033670A1 Method and compositions for producing berry derived products
06/15/2000WO2000033667A2 Bioflavonoids, anthocyanins and phenol compounds from cherries as antioxidants
06/15/2000WO2000033659A1 Compositions for treating alzheimer's disease and other amyloidoses
06/15/2000WO2000033654A1 Use of protease inhibitors to modulate cellular pathways, immunity and therapies associated therewith
06/15/2000WO2000023618A8 Polymorphism in a tgf-beta gene correlated to osteoporosis
06/15/2000WO2000015231A8 Adenosine a3 receptor modulators
06/15/2000WO2000013672A9 New solid dose form of nanoparticulate naproxen
06/15/2000WO2000012101A3 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
06/15/2000WO2000012071A3 Pharmaceutical and/or diet product
06/15/2000WO2000011000A3 New compounds
06/15/2000WO2000010988A8 Water soluble analogs and prodrugs of paclitaxel
06/15/2000WO2000010600A3 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000009531A3 β-L-2'-DEOXY-NUCLEOSIDES FOR THE TREATMENT OF HEPATITIS B
06/15/2000WO2000009500A3 Nematicidal pyrazoles
06/15/2000WO2000009107A3 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders
06/15/2000WO2000009071A3 A novel liposomal formulation useful in treatment of cancer and other proliferation diseases
06/15/2000WO2000006701A9 Improvement of cardiac function by mesenchymal stem cell transplantation
06/15/2000WO2000006531A3 Nitric esters and nitrate salts of specific drugs
06/15/2000WO2000006088A3 Inhibitors of redox signaling and methods of using same
06/15/2000WO2000003748A3 Compositions which contain triterpenes for regulating hair growth
06/15/2000WO2000002550A3 Acetylpiperazines for modulating sexual activity
06/15/2000WO2000002546A3 Use of caba-analogues for treating insomnia
06/15/2000WO2000000469A3 Alkyl ketones as potent anti-cancer agents
06/15/2000WO1999066915A3 Therapeutic applications of estrogenic carboxylic acids
06/15/2000WO1999066910A3 Agents for specifically inhibiting osteoclastic bone resorption
06/15/2000WO1999062502A3 Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
06/15/2000WO1999061056A9 Methods and products for inducing mucosal immunity
06/15/2000WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
06/15/2000WO1999059562A9 Method of treating or preventing abnormal cardiac cell growth by inhibiting the 12-lipoxygenase pathway
06/15/2000WO1999055847A3 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus
06/15/2000WO1999047669A3 Human nucleic acid sequences from tissue of breast tumors
06/15/2000WO1999045016A3 Novel prodrugs for phosphorus-containing compounds
06/15/2000WO1999038503A8 Pharmacological uses of optically pure (+)-bupropion
06/15/2000WO1999002550A8 Ctl epitopes from ebv
06/15/2000WO1998051278A3 High efficiency encapsulation of charged therapeutic agents in lipid vesicles
06/15/2000DE19958246A1 Isochinuclidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende therapeutische Mittel gegen Hypercholesterinämie Isochinuclidinderivate, processes for their preparation containing these compounds and therapeutic agents for hypercholesterolemia
06/15/2000DE19906977C1 Transdermal patch for administering deoxypeganin, useful for treating dementia-associated cognitive impairment and preventing intoxication by organic thiophosphate esters
06/15/2000DE19857490A1 Cosmetic or dermatological skin-protective compositions, containing saturated and unsaturated phosphatidyl choline to give good barrier stabilizing and active agent penetrating effects
06/15/2000DE19857475A1 Substituierte Cycloheptene, deren Herstellung und Verwendung Substituted cycloheptenes, their preparation and use
06/15/2000DE19857151A1 Powdered, water-soluble chlorhexidine salt, useful e.g. as disinfectant in cosmetics, contains anion from specific sugar acids or their lactones
06/15/2000DE19857009A1 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren Preparation with improved therapeutic index containing nucleotide synthesis
06/15/2000DE19856668A1 Wirkstoffmatrix in Form eines biologisch resorbierbaren porösen Vlieses, Verfahren zu ihrer Herstellung und Verwendung Active substance matrix in the form of a biologically resorbable porous nonwoven, methods for their preparation and use
06/15/2000DE19856432A1 Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen Nanoparticulate core-shell systems and their use in pharmaceutical and cosmetic preparations
06/15/2000DE19844343A1 Homoeopathic remedy for male or female potency disorders comprises orally administered diluted bile drops
06/15/2000CA2732620A1 Crystalline form of 40-o-(2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000CA2651609A1 Crystalline form of 40-o- (2-hydroxy-ethyl) rapamycin and process for preparation thereof
06/15/2000CA2380391A1 Transdermal patch for delivering volatile liquid drugs
06/15/2000CA2363310A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
06/15/2000CA2359928A1 Pgt and apoptosis
06/15/2000CA2354766A1 Prodrug compounds and process for preparation thereof
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2354266A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000CA2354233A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000CA2354188A1 Cancer cell vaccine
06/15/2000CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
1 ... 6299 6300 6301 6302 6303 6304 6305 6306 6307 6308 6309 6310 6311 6312 6313 6314 6315 6316 6317 6318 6319 ... 7860